Denver Health and Hospital Authority
Denver, Colorado, 80204-4507, United States
NCT Number: NCT05002829
The purpose of this study is to see if decreasing the amount of antibiotics after appendicitis surgery can decrease the risk of adverse effects associated with antibiotics while at the same time ensuring participant safety.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Denver, Colorado, 80204-4507, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Standard of Care Antibiotic use will be restricted to none or up to 24 hours of post-operative antibiotics.
Standard of Care Antibiotic use will be permitted for 24 hours or up to 4 days of post-operative antibiotics.
Time frame: Up to 40 days after appendicitis surgery
As assessed by treating physician
Time frame: Up to 30 days after appendicitis surgery
Infectious/antibiotic complication requiring antibiotic treatment only, Emergency Department visit, hospital readmission, percutaneous drainage, and operative intervention as assessed by treating physician.
Time frame: Up to 30 days after appendicitis surgery
As assessed by treating physician
Denver Health and Hospital Authority
Other
Complex And Simple Appendicitis: REstrictive or Liberal Post-operative Antibiotic eXposure (CASA RELAX) Using Desirability of Outcome Ranking (DOOR) and Response Adjusted for Duration of Antibiotic Risk (RADAR): A Randomized Controlled Trial at Denver Health
Acronym: CASARELAX
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05887414
Appendicitis, Cecal Diseases
Baldwin Park, California, United States
View Trial DetailsNCT05209061
Appendicitis, Cecal Diseases
Copenhagen, Denmark
View Trial DetailsNCT04986397
Appendicitis, Cecal Diseases
Boston, Massachusetts, United States
View Trial DetailsNCT04614519
Appendectomy, Appendicitis
Nice, France
View Trial Details